Top 10 Cannabis Studies the Government Wished it Had Never Funded

Top 10 Cannabis Studies the Government Wished it Had Never Funded

A massive study of California HMO members funded by the National Institute on Drug Abuse (NIDA) found marijuana use caused no significant increase in mortality. Tobacco use was associated with increased risk of death. Sidney, S et al. Marijuana Use and Mortality. American Journal of Public Health. Vol. 87 No. 4, April 1997. p. 585-590. Sept. 2002.

Veterans Affairs scientists looked at whether heavy marijuana use as a young adult caused long-term problems later, studying identical twins in which one twin had been a heavy marijuana user for a year or longer but had stopped at least one month before the study, while the second twin had used marijuana no more than five times ever. Marijuana use had no significant impact on physical or mental health care utilization, health-related quality of life, or current socio-demographic characteristics. Eisen SE et al. Does Marijuana Use Have Residual Adverse Effects on Self-Reported Health Measures, Socio-Demographics or Quality of Life? A Monozygotic Co-Twin Control Study in Men. Addiction. Vol. 97 No. 9. p.1083-1086. Sept.

Marijuana is often called a “gateway drug” by supporters of prohibition, who point to statistical “associations” indicating that persons who use marijuana are more likely to eventually try hard drugs than those who never use marijuana – implying that marijuana use somehow causes hard drug use. But a model developed by RAND Corp. researcher Andrew Morral demonstrates that these associations can be explained “without requiring a gateway effect.” More likely, this federally funded study suggests, some people simply have an underlying propensity to try drugs, and start with what’s most readily available. Morral AR, McCaffrey D and Paddock S. Reassessing the Marijuana Gateway Effect. Addiction. December 2002. p. 1493-1504.

The White House had the National Research Council examine the data being gathered about drug use and the effects of U.S. drug policies. NRC concluded, “the nation possesses little information about the effectiveness of current drug policy, especially of drug law enforcement.” And what data exist show “little apparent relationship between severity of sanctions prescribed for drug use and prevalence or frequency of use.” In other words, there is no proof that prohibition – the cornerstone of U.S. drug policy for a century – reduces drug use. National Research Council. Informing America’s Policy on Illegal Drugs: What We Don’t Know Keeps Hurting Us. National Academy Press, 2001. p. 193.

DOES PROHIBITION CAUSE THE “GATEWAY EFFECT”?): U.S. and Dutch researchers, supported in part by NIDA, compared marijuana users in San Francisco, where non-medical use remains illegal, to Amsterdam, where adults may possess and purchase small amounts of marijuana from regulated businesses. Looking at such parameters as frequency and quantity of use and age at onset of use, they found no differences except one: Lifetime use of hard drugs was significantly lower in Amsterdam, with its “tolerant” marijuana policies. For example, lifetime crack cocaine use was 4.5 times higher in San Francisco than Amsterdam. Reinarman, C, Cohen, PDA, and Kaal, HL. The Limited Relevance of Drug Policy: Cannabis in Amsterdam and San Francisco. American Journal of Public Health. Vol. 94, No. 5. May 2004. p. 836-842.

Federal researchers implanted several types of cancer, including leukemia and lung cancers, in mice, then treated them with cannabinoids (unique, active components found in marijuana). THC and other cannabinoids shrank tumors and increased the mice’s lifespans. Munson, AE et al. Antineoplastic Activity of Cannabinoids. Journal of the National Cancer Institute. Sept. 1975. p. 597-602.

In a 1994 study the government tried to suppress, federal researchers gave mice and rats massive doses of THC, looking for cancers or other signs of toxicity. The rodents given THC lived longer and had fewer cancers, “in a dose-dependent manner” (i.e. the more THC they got, the fewer tumors). NTP Technical Report On The Toxicology And Carcinogenesis Studies Of 1-Trans- Delta-9-Tetrahydrocannabinol, CAS No. 1972-08-3, In F344/N Rats And B6C3F Mice, Gavage Studies. See also, “Medical Marijuana: Unpublished Federal Study Found THC-Treated Rats Lived Longer, Had Less Cancer,” AIDS Treatment News no. 263, Jan. 17, 1997.

Researchers at the Kaiser-Permanente HMO, funded by NIDA, followed 65,000 patients for nearly a decade, comparing cancer rates among non-smokers, tobacco smokers, and marijuana smokers. Tobacco smokers had massively higher rates of lung cancer and other cancers. Marijuana smokers who didn’t also use tobacco had no increase in risk of tobacco-related cancers or of cancer risk overall. In fact their rates of lung and most other cancers were slightly lower than non-smokers, though the difference did not reach statistical significance. Sidney, S. et al. Marijuana Use and Cancer Incidence (California, United States). Cancer Causes and Control. Vol. 8. Sept. 1997, p. 722-728.

Donald Tashkin, a UCLA researcher whose work is funded by NIDA, did a case-control study comparing 1,200 patients with lung, head and neck cancers to a matched group with no cancer. Even the heaviest marijuana smokers had no increased risk of cancer, and had somewhat lower cancer risk than non-smokers (tobacco smokers had a 20-fold increased lung cancer risk). Tashkin D. Marijuana Use and Lung Cancer: Results of a Case-Control Study. American Thoracic Society International Conference. May 23, 2006.

In response to passage of California’s medical marijuana law, the White House had the Institute of Medicine (IOM) review the data on marijuana’s medical benefits and risks. The IOM concluded, “Nausea, appetite loss, pain and anxiety are all afflictions of wasting, and all can be mitigated by marijuana.” While noting potential risks of smoking, the report added, “we acknowledge that there is no clear alternative for people suffering from chronic conditions that might be relieved by smoking marijuana, such as pain or AIDS wasting.” The government’s refusal to acknowledge this finding caused co-author John A. Benson to tell the New York Times that the government “loves to ignore our report … they would rather it never happened.” Joy, JE, Watson, SJ, and Benson, JA. Marijuana and Medicine: Assessing the Science Base. National Academy Press. 1999. p. 159. See also, Harris, G. FDA Dismisses Medical Benefit From Marijuana. New York Times. Apr.
21, 2006


The Cannabis Timeline – JPG

Click the above image to see the Cannabis Timeline

It’s a huge image, it will open in a new window and take a moment or two to load.

Psychedelic Mushrooms from Outter Space!

Post compiled by Andrew Rutajit


From Popular Science:


Mysterious red cells might be aliens
By Jebediah Reed – Popular Science

As bizarre as it may seem, the sample jars brimming with cloudy, reddish rainwater in Godfrey Louis’s laboratory in southern India may hold, well, aliens.

In April, Louis, a solid-state physicist at Mahatma Gandhi University, published a paper in the prestigious peer-reviewed journal Astrophysics and Space Science in which he hypothesizes that the samples — water taken from the mysterious blood-colored showers that fell sporadically across Louis’s home state of Kerala in the summer of 2001 — contain microbes from outer space.

(more) From Popular Science

“Stranger still, dozens of his experiments suggest that the particles may lack DNA yet still reproduce plentifully, even in water superheated to nearly 600 degrees Fahrenheit . (The known upper limit for life in water is about 250 degrees Fahrenheit .)”

More here:

Read more of this post

Mescaline, LSD, Psilocybin and Personality Change

Mescaline, LSD, Psilocybin and Personality Change

Sanford M. Unger, Ph.D.*

from: Psychiatry: Journal for the Study of Interpersonal Processes
Vol. 26, No. 2, May, 1963. © The William Alanson White Psychiatric Foundation

. . . our normal waking consciousness . . . is but one special type of consciousness, whilst all about it, parted from it by the filmiest of screens, there lie potential forms of consciousness entirely different…. No account of the universe in its totality can be final which leaves these . . . disregarded. How to regard them is the question—for they are so discontinuous with ordinary consciousness.—William James. (1)


In recent years, how to regard the “forms of consciousness entirely different” induced by mescaline, LSD-25, and psilocybin has posed a seemingly perplexing issue. For articulate self-experimenters from Mitchell to Huxley, mescaline has provided many-splendored visual experiences, or a life-enlarging sojourn in “the Antipodes of the mind” (2). For Stockings, it may be recalled, mescaline produced controlled schizophrenia (3)—a thesis which earned the Bronze Medal of the Royal Medico-Psychological Association and apparently inaugurated, in conjunction with the advent of LSD-25, a period of concerted chemical activity in the exploration and experimental induction of “model psychoses” (4). In counterpoint, this same so-called “psychotomimetic” LSD has increasingly found use as a purposeful intervention or “adjuvant” in psychotherapy (5). The recently arrived “magic mushroom,” psilocybin, has been similarly equivocal—”psychotogenic” for some, “mysticomimetic” for others (6). The present paper will review the literature on drug experience—paying particular attention to the effects of extradrug variables, for the realization of the extent of their potential influence has only recently crystallized, and promises to reduce some of the abundant disorder in this area.

The phenomenon of drug-associated rapid personality or behavior change will be discussed in some detail. For example, a number of different alcoholic treatment facilities, especially in Canada, have reported, for many of their patients, complete abstinence after a single LSD session (7). More generally, neurotic ailments over the full range have been described as practically evaporating (8). Given this picture, and the present state and practice of the therapeutic art, it is not surprising to find at least one psychiatrist envisioning “. . . mass therapy: institutions in which every patient with a neurosis could get LSD treatment and work out his problems largely by himself” (9). James would have been much attracted by the “spectacular and almost unbelievable results” (10) reported on the modern drug scene; and, in fact, their resemblance to the “instantaneous transformations” attendant on “mystical” religious conversions —which he discussed so eloquently—may well be more than superficial and seems worthy of attention.

The Equivalent Action of Mescaline, LSD-25, and Psilocybin

Since the evidence and testimony accumulated over the years on the separate drugs will be treated interchangeably, this raises a preliminary point of some importance. Although the conclusion was delayed by both dissimilarities in their chemical structure and differing modes of introduction to the scientific community, it is now rather commonly adjudged that the subjective effects of mescaline, LSD-25, and psilocybin are similar, equivalent, or indistinguishable. Both Isbell and Abramson have administered LSD and psilocybin in the same study; Wolbach and his co-workers have administered all three. All have found that their subjects were unable to distinguish between the drugs (11).

The reported equivalence in subjective reactions seems quite consistent—or at least not inconsistent—with present pharmacodynamic knowledge. Studies of radioactively tagged mescaline and LSD indicate that the compounds largely disappear from the brain in relatively short order—in fact, at about the same time that the first “mental phenomena” make their appearance (12). Hence, it has been tentatively suggested that the characteristic effects, which persist for a relatively long period, are to be attributed not to the action of the drug itself but to some as yet unidentified aspect of the chain of events triggered by drug administration. Isbell, observing the “remarkably similar” reactions to LSD and psilocybin, hypothesized “some common biochemical or physiological mechanism” to be responsible for the effects—that is, that the various compounds share a final common path (13). The most direct support for this inference of biological identity in ultimate mechanism of action has come from cross-tolerance studies wherein subjects rendered tolerant to one drug—that is, nonreactive after repeated administrations —have then been challenged by a different drug. Present indications are that cross-tolerance among the drugs does in fact develop (14).

This is not intended to suggest that a drug experience is invariable among subjects—quite the contrary has been the case. In fact, experiences even for the same subject differ from one session to the next (15). But when relevant extradrug variables are controlled, the within-drug variance is apparently coextensive with between-drug variance, and is attributable to ubiquitous personality differences; in other words, while a range of reactions is reported to all of the drugs, there is no reaction distinctively associated with any particular drug. Extradrug variables, which have been uncontrolled and largely unrecognized until recently, are apparently responsible for much of the variance erroneously attributed to specific drug action.

Read more of this post

DMT – Nature’s Quest for Consciousness

DMT – Nature’s Quest for Consciousness

by Andrew Rutajit

Our perception of reality is strongly based upon a delicate balance of chemicals. Altering these chemicals, often resulting in altered states of consciousness and profound inner visual experiences, has been the goal of the shaman for millennia. Today, we have all but abandoned this technique; we are derailing millions of years of human evolution by saturating our reality with materialism, religion, porn, and fried food on a stick. We have traded altering our consciousness via plant-based shamanic techniques for altering our consciousness with electronic media and sugar. A global return to the shamanic techniques of ecstasy could get us back on track. However, power-hungry men on religious crusades long ago demonized and criminalized these shamanic techniques. They wedged themselves between the “pagans” and the direct blissful experience provided naturally by numerous ethnobotanicals. Still today, these people have positioned themselves in such a way that they have become the only “religious experience” available. The foundation of human evolution has been laid upon a persistent quest for more and more consciousness. This combination of religion, materialism, and addiction to entertainment has all but suppressed our natural desire to expand our consciousness. Ironically, an archaic revival may be a giant step to regain a forward direction in our evolutionary drive for more and more consciousness.

DMT, the most potent psychedelic compound known to exist, is manufactured in the ventricle (third eye) system in the human brain. Previously, anatomists relegated these ventricles to a position of little importance; simply calling them bags of fluid used for shock absorption in case of trauma – such as a blow to the head. Occult anatomists, alchemists, and symbolic mythologists have known for millennia that these fluid-filled sacks and the pineal gland that lies directly in the center of it all are connected to consciousness. It has long been speculated that our consciousness exists holistically within the entire chemical and cell composition of the brain. Consequently, the ventricle system of the brain, cerebrospinal fluid, and DMT are all now in the game as a players in the complex question of consciousness. DMT is present in our brains in higher than normal doses during the birth process, higher than normal doses of DMT (possibly a result of REM) may be responsible for vivid dreams during sleep, and DMT is also present in our brains in high doses at the time of death. It is also the active ingredient in the Amazonian shaman’s psychedelic brew called “Ayahuasca.” This is important. It is worth reiteration – this naturally occurring, extremely psychedelic compound is the chemical link to the profound inner visual experiences reported by Amazonian shaman, lucid dreamers and those reporting near death experiences.

Read more of this post

%d bloggers like this: